Caribou Biosciences Balance Sheet (2020-2026)

Reported Financials

Caribou Biosciences Quarterly Balance Sheet

Periods 26 quarters

Latest Jun 2026

Caribou Biosciences reported total assets of $142.77M and total liabilities of $44.67M for the quarter ended Jun 2026, down 35.4% year over year. This balance sheet covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	435.31M	240.42M	147.63M	112.15M	82.08M	58.34M	52.74M	66.19M	104.06M	51.16M	49.40M	37.87M	31.97M	16.29M	29.42M	25.20M	11.14M	12.36M	12.06M	26.19M
Short-term InvestmentsInvestments (Current)		135.41M	206.10M	227.78M	211.28M	189.32M	175.79M	193.04M	234.43M	277.67M	244.59M	223.78M	196.21M	193.24M	179.05M	158.75M	136.12M	126.98M	105.57M	86.12M
Cash & Current Investments	435.31M	375.83M	353.73M	339.92M	293.37M	247.66M	228.54M	259.23M	338.49M	328.83M	293.99M	261.65M	228.18M	209.54M	208.47M	183.95M	147.26M	139.34M	117.63M	112.31M
Receivables - NetNet Receivables	0.58M	1.15M	0.37M	0.52M	0.40M	0.20M	1.53M	0.77M	1.13M	0.15M	0.92M	0.21M	0.18M	0.27M	0.09M	0.07M	0.24M	0.07M	0.23M	0.20M
Receivables - OtherOther Receivables	5.35M	5.48M	4.17M	3.09M	2.70M	2.25M	1.67M	1.50M	2.35M	2.29M	1.73M	1.73M	1.68M	1.83M	1.84M	1.96M	1.83M	1.90M	1.45M	1.14M
Receivables	5.93M	6.64M	4.54M	3.62M	3.10M	2.45M	3.20M	2.26M	3.48M	2.43M	2.64M	1.94M	1.87M	2.09M	1.93M	2.03M	2.07M	1.97M	1.67M	1.34M
Prepaid Assets	5.95M	7.24M	8.24M	7.29M	8.56M	7.92M	6.11M	5.56M	7.07M	6.16M	6.91M	6.32M	6.58M	6.59M	6.12M	5.78M	5.32M	2.91M	2.39M	2.34M
Current Assets	449.05M	391.19M	368.01M	352.93M	306.92M	260.25M	239.49M	268.54M	350.69M	338.84M	304.51M	270.88M	237.43M	219.38M	217.32M	192.51M	155.51M	145.23M	122.38M	116.59M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	4.48M	4.89M	6.02M	8.01M	8.96M	10.68M	12.65M	15.43M	16.60M	18.27M	19.17M	19.88M	19.57M	19.28M	18.52M	8.18M	7.60M	6.76M	6.12M	5.50M
Long-Term Investments	7.63M	37.68M	37.09M	26.15M	49.22M	69.37M	62.45M	33.29M	58.22M	43.58M	51.94M	50.12M	52.84M	39.85M	9.27M	0.13M	11.95M	3.50M	1.00M	1.50M
Other Non-Current Assets	0.81M	0.97M	1.46M	1.30M	1.34M	1.54M	1.48M	1.42M	1.57M	1.59M	1.79M	1.64M	4.74M	5.52M	5.04M	3.62M	3.78M	2.20M	2.14M	2.14M
Non-Current Assets	12.91M	51.16M	77.99M	68.44M	91.90M	113.52M	107.97M	81.11M	106.83M	93.37M	102.31M	102.06M	106.91M	93.94M	56.33M	28.40M	39.48M	30.14M	26.62M	26.18M
Assets	461.96M	442.36M	446.00M	421.37M	398.82M	373.76M	347.46M	349.65M	457.52M	432.21M	406.82M	372.94M	344.33M	313.31M	273.66M	220.90M	194.98M	175.37M	149.00M	142.77M
Liabilities
Current Liabilities
Accounts Payables	3.48M	3.99M	1.81M	0.43M	1.23M	1.15M	2.65M	4.43M	2.38M	3.12M	5.94M	3.23M	2.70M	2.48M	3.87M	3.24M	3.80M	5.78M	3.50M	3.08M
Payables	3.48M	3.99M	1.81M	0.43M	1.23M	1.15M	2.65M	4.43M	2.38M	3.12M	5.94M	3.23M	2.70M	2.48M	3.87M	3.24M	3.80M	5.78M	3.50M	3.08M
Accumulated Expenses	13.93M	13.14M	11.19M	14.91M	14.64M	16.08M	12.54M	15.90M	18.23M	21.14M	18.99M	23.63M	25.45M	23.62M	19.89M	20.53M	19.35M	16.54M	13.89M	13.14M
Current Deferred Revenue	0.10M	8.70M	0.10M		12.04M	9.94M	10.88M	12.96M	2.83M	2.85M	2.83M	2.83M	2.83M	3.13M	2.83M	2.83M	2.22M	1.90M	0.99M	0.37M
Total Current Liabilities	26.16M	25.83M	26.67M	28.86M	28.81M	28.13M	27.10M	34.38M	24.57M	28.30M	29.02M	30.94M	32.16M	30.65M	28.49M	28.89M	28.06M	25.41M	19.67M	17.97M
Non-Current Liabilities
Non-Current Debt
Non-Current Deffered Revenue	23.02M	22.03M	17.33M	15.63M	15.42M	15.95M	13.91M	18.16M	6.73M	6.10M	5.43M	4.60M	3.95M	3.32M	2.62M	1.77M	1.76M	1.75M	1.65M	1.42M
Preferred Stock Liabilities
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax	0.15M	0.48M	0.48M	0.47M	0.47M	0.38M	0.38M	0.38M	0.38M	0.56M	0.56M	0.56M	0.56M	0.55M	0.55M	0.55M	0.55M
Operating Leases			27.24M	27.09M	26.96M	26.78M	26.40M	26.16M	26.32M	25.91M	25.89M	25.53M	25.46M	25.06M	24.32M	23.56M	22.78M	26.03M	25.66M	25.28M
Other Non-Current Liabilities	1.83M	2.10M	0.01M
Total Non-Current Liabilities	55.73M	52.43M	74.19M	73.48M	74.71M	72.89M
Total Liabilities	57.56M	54.53M	74.20M	73.48M	74.71M	72.89M	69.19M	80.19M	59.25M	63.81M	63.54M	62.47M	63.13M	60.36M	56.43M	54.77M	53.14M	53.19M	46.98M	44.67M
Shareholder's Equity
Total Debt
Common Equity	404.40M	387.82M	371.80M	347.89M	324.11M	300.87M	278.27M	269.46M	398.27M	368.40M	343.29M	310.46M	281.20M	252.95M	217.22M	166.13M	141.84M	122.17M	102.02M	98.10M
Liabilities and Shareholders Equity	461.96M	442.36M	446.00M	421.37M	398.82M	373.76M	347.46M	349.65M	457.52M	432.21M	406.82M	372.94M	344.33M	313.31M	273.66M	220.90M	194.98M	175.37M	149.00M	142.77M
Retained Earnings	-79.31M	-97.79M	-116.90M	-143.60M	-170.23M	-197.22M	-225.30M	-254.80M	-264.80M	-299.29M	-340.52M	-378.22M	-412.90M	-448.39M	-488.40M	-542.50M	-570.03M	-596.51M	-621.60M	-645.90M
Preferred Shares

Caribou Biosciences Balance Sheet API

Pull Caribou Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CRBU&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "CRBU", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=CRBU&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Caribou Biosciences CRBU Balance Sheet (2020-2026)

Caribou Biosciences Quarterly Balance Sheet

Caribou Biosciences Balance Sheet API

Create an account

Sign In

Reset Password